Jeremy S. Abramson, MD¹, Kristie A. Blum, MD², Ian W. Flinn, MD, PhD³, Martin Gutierrez, MD^4*, Andre Goy, MD⁵, Michael Maris, MD⁶, Michael Cooper, MD⁷, Michael O'Meara, MS^7*, Darrell Borger, PhD^8*, Jennifer Mertz, PhD^7*, Robert J. Sims, PhD^7*, Supko Jeffrey, PhD^9* and Anas Younes, MD¹⁰

¹Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
²Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
³Sarah Cannon Research Institute, Nashville, TN
⁴John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁵John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁶Colorado Blood Cancer Institute, Denver, CO
⁷Constellation Pharmaceuticals, Cambridge, MA
⁸Massachusetts General Hospital, Boston, MA
⁹Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, MA
¹⁰Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Ian W. Flinn, MD, PhD^1,2, Thomas J. Ervin, MD^1,3*, Ralph V. Boccia, MD⁴, Douglas B. Flora, MD^1,5*, J. Daniel Cuevas, MD^6*, Dana S. Thompson, MD^1,2*, Dianna L. Shipley, MD^1,2* and Jesus G. Berdeja, MD^1,2

¹Sarah Cannon Research Institute, Nashville, TN
²Tennessee Oncology, PLLC, Nashville, TN
³Florida Cancer Specialists, Englewood, FL
⁴The Center for Cancer and Blood Disorders, Bethesda, MD
⁵Oncology Hematology Care, Inc., Cincinnati, OH
⁶St. Louis Cancer Care, LLP, Bridgton, MO

Anas Younes, MD¹, Gilles Salles², Giovanni Martinelli³, R. Gregory Bociek, MD⁴, Dolores Caballero Barrigon, MD^5*, Eva Gonzalez Barca^6*, Mehmet Turgut, MD, PhD^7*, John F. Gerecitano, MD⁸, Fabian Herbst^9*, Lisa Williams^10*, Nabanita Mukherjee^11*, Ranjana Tavorath^10* and Won Seog Kim, MD, PhD^12*

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Centre Hospitalier Lyon-Sud, Pierre-Benite, France
³European Institute of Oncology, Milan, Italy
⁴University of Nebraska Medical Center, Omaha, NE
⁵Hospital Universitario de Salamanca, Salamanca, Spain
⁶Hospital Duran I Reynals-ICO, Barcelona, Spain
⁷Ondokuz Mayis University, Samsun, Turkey
⁸Memorial Sloan Kettering Cancer Center, New York, NY
⁹Novartis Pharma AG, Basel, Switzerland
¹⁰Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹¹Novartis Healthcare Pvt Ltd, Hyderabad, India
¹²Samsung Medical Center, Seoul, South Korea

Cecilia Carpio, MD^1*, Loïc Ysebaert, MD PhD^2*, Raúl Cordoba, MD^3*, Armando Santoro, MD^4*, José Antonio López-Martín, MD^5*, Juan Manuel Sancho, MD, PhD^6*, Carlos Panizo, PhD^7*, Mecide Meric Gharibo, MD^8*, Drew W Rasco, MD^9*, Anne-Marie Stoppa, MD¹⁰, Sylvia Damian, MD^11*, Xin Wei^12*, Patrick Hagner, PhD^12*, Kristen Hege¹³, Soraya Carrancio, PhD^14*, Anita K. Gandhi, PhD^12*, Michael Pourdehnad, MD^13* and Vincent Ribrag, MD¹⁵

¹Hospital Vall d'Hebron, Barcelona, Spain
²Département d'Hématologie, IUCT-Oncopole, Toulouse, France
³Hospital Fundación Jiménez-Díaz, Madrid, Spain
⁴Fondazione ‘G.Pascale’, IRCCS, Istituto Nazionale Tumori, Naples, Italy
⁵12 de Octubre University Hospital, Madrid, Spain
⁶Clinica Universidad de Navarra, Pamplona, Spain
⁷Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
⁸Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁹START, San Antonio, TX
¹⁰Institut Paoli Calmettes, Marseille, France
¹¹Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
¹²Celgene Corporation, Summit, NJ
¹³Celgene Corporation, San Francisco, CA
¹⁴Celgene Institute for Translational Research Europe, Seville, Spain
¹⁵Service d'Hématologie, Institut Gustave Roussy, Villejuif, France

Carmelo Carlo-Stella, MD¹, Richard Delarue, MD², Prajak J Barde, MD^3*, Lydia Scarfo^4*, Thamila Saheb^2*, Uday Kumar^3*, Srikant Viswanadha, PhD^5*, Sara Gandolfi, MD^6*, Valeria Pittari, MD^1*, Armando Santoro, MD^7*, Silvia Laura Locatelli, PhD^8*, Swaroop Vakkalanka, PhD^3*, Paolo Ghia, MD, PhD⁹ and Andres J.M. Ferreri¹⁰

¹University of Milano and Humanitas Research Hospital, Milano, Italy
²URC/CIC Paris Descartes Necker-Cochin, Paris, France
³Rhizen Pharmaceuticals SA, La Chaux-de-Fonds, Switzerland
⁴Unit of Lymphoid Malignancies, Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy
⁵Incozen Therapeutics Pvt. Ltd., Hyderabad, India
⁶Hematology Unit, Humanitas Cancer Center, Rozzano, Italy
⁷Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy
⁸Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy
⁹Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milano, Italy
¹⁰IRCCS San Raffaele Scientific Institute, Milano, Italy

Jonathon B. Cohen, MD¹, Lai Wei, PhD^2*, Kami J. Maddocks, MD³, Leonard T. Heffner, MD¹, Amelia Langston, MD¹, Christopher Flowers, MD⁴, Steven M. Devine, MD⁵ and Kristie A. Blum, MD⁶

¹Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA
²Division of Biostatistics, The Ohio State University, Columbus, OH
³Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁴Winship Cancer Institute of Emory University, Atlanta, GA
⁵Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁶Division of Hematology, The Ohio State University, Columbus, OH

Fernando Cabanillas, MD^1,2,3, Noridza Rivera, MD^1,2*, Orestes Pavia, MD^1*, Wandaly I. Pardo, MD^1* and Margarita Bruno, MD^1*

¹Auxilio Cancer Center, Hospital Auxilio Mutuo, San Juan, PR
²University of Puerto Rico School of Medicine, San Juan, PR
³MD Anderson Cancer Center, U. Texas, Houston, TX

Alexey V Danilov, M.D. Ph.D.¹, Hongli Li, PhD^2*, Oliver W. Press³, Ilan Shapira, MD⁴, Lode J. Swinnen, MBChB⁵, Ariela Noy, MD⁶, Erin Reid, MD⁷, Sonali M. Smith, MD⁸ and Jonathan W. Friedberg, MD, MMSc⁹

¹OHSU Knight Cancer Institute, Portland, OR
²SWOG Statistical Center, Seattle, WA
³Fred Hutchinson Cancer Rsch. Ctr., Seattle
⁴Hematology-Oncology, Mount Sinai Beth Israel, New York, NY
⁵Medical Oncology, Johns Hopkins, Baltimore, MD
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷University of California at San Diego, San Diego, CA
⁸University of Chicago, Chicago, IL
⁹University of Rochester, Rochester, NY

Mary Gleeson^1*, Kim Linton^2*, Clare Peckitt^1*, Adam Gibb^2*, Eliza A Hawkes^1*, Morgan Back^2*, Binnaz Yasar^2*, Kate Foley^2*, Rebecca Lee^2*, Joanna Dash^2*, Hannah Johnson^2*, Catherine O'Hara^2*, Andrew Wotherspoon^1*, Ayoma Attygalle^1*, Michael Potter¹, Mark E Ethell, MBBChir, MA, FRCP, FRCPath^3*, Claire Dearden^1*, John Radford^2*, Ian Chau^4* and David Cunningham^1*

¹The Royal Marsden Hospital, London and Surrey, United Kingdom
²The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
³Haemato-Oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁴The Royal Marsden Hospital, Surrey, United Kingdom

Mary Kathryn Malecek, MD^1*, Shaina Rozell, MD², Benjamin A. Chu^1*, Trifilio Steve, Pharm D^2*, Natalie Galanina, MD³, Chadi Nabhan, MD⁴ and Adam M. Petrich, MD⁵

¹Feinberg School of Medicine, Northwestern University, Chicago, IL
²Division of Hematology/Oncology, Northwestern University, Chicago, IL
³Division of Hematology/Oncology, University of Chicago, Chicago, IL
⁴Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL
⁵Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL

Matthew J Maurer, MS¹, Fredrik Ellin, MD, MSc^2*, James Cerhan, MD, PhD¹, Stephen Ansell, MD, PhD³, Brian K Link, MD⁴, Mats Jerkeman, MD, PhD⁵, Karin E Smedby, MD, PhD^6*, Carrie A. Thompson, MD⁷, William Macon, MD^3*, Sergei Syrbu, MD^8*, Susan L. Slager, PhD¹, Thomas E. Witzig, MD⁷, Thomas M. Habermann, MD⁷, Thomas Relander, MD, PhD^9* and Andrew L Feldman, MD³

¹Department of Health Sciences Research, Mayo Clinic, Rochester, MN
²Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden
³Mayo Clinic, Rochester, MN
⁴Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁵Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden
⁶Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸University of Iowa, Iowa City, IA
⁹Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden

Dai Chihara, MD, PhD¹, Mohamed Amin Ahmed, MD^1*, Yasuhiro Oki, MD¹, Jason R Westin, MD¹, Fredrick B. Hagemeister, MD¹, Jorge E. Romaguera, MD¹, Michelle A. Fanale¹, Hun Ju Lee, MD^1*, Francesco Turturro, MD¹, Felipe Samaniego, MD¹, Sattva S. Neelapu, MD¹, Alma Rodriguez, M.D.^1*, Nathan Fowler, MD¹, Michael Wang, MD¹, Luis E. Fayad, MD¹, Richard Eric Davis, M.D.^2* and Loretta Nastoupil, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston

Marcel Nijland, MD^1*, Karin Boslooper, MD^1*, Anke Van den Berg, PhD², Hanneke C. Kluin-Nelemans, MD, PhD¹, Peter Joosten, MD³, Huib Storm, MD, PhD^4*, Robby Kibbelaar, MD, PhD^5*, Gustaaf van Imhoff, MD, PhD¹ and Mels Hoogendoorn, MD, PhD^3*

¹Department of Hematology, Groningen University Medical Center, University of Groningen, Groningen, Netherlands
²Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
³Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands
⁴Certe Leeuwarden, Leeuwarden, Netherlands
⁵Department of Pathology, Pathologie Friesland, Leeuwarden, Netherlands

Roberto A. Ferro, MD¹, Vijaya R. Bhatt, MD², Martin Bast, BS^1*, Lynette Smith, MS^1*, R. Gregory Bociek, MD¹, Matthew A. Lunning, DO¹, Philip J Bierman, MD³, Julie M. Vose, MD¹ and James O. Armitage, MD¹

¹University of Nebraska Medical Center, Omaha, NE
²Hematology-Oncology, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE
³Univ. of Nebraska Medical Center, Omaha, NE

Emilie Reboursiere^1*, Fabien Le Bras^2*, Franck Morschhauser, MD^3*, Emmanuel Gyan, MD, PhD⁴, Aline Clavert, MD^5*, Sandra Malak^6*, David Sibon, MD^7,8*, Marion Damge^9*, Claude Gardin^10*, Luc-Matthieu Fornecker^11*, Reda Garidi^12*, Sabine Tricot^13*, Roch Houot^14*, Bertrand Joly, MD^15*, Wajed Abarah, MD^16*, Bachra Choufi, MD^17*, Anne-dominique Pham^1*, Sylvain P Chantepie, MD^18*, Christophe Fruchart, MD^19*, Anne-Claire Gac^1*, Catherine Ollivier^20,21*, Emilie Marin^1*, Violaine Safar^22*, Anne Parcelier, MD^23,24*, Herve Maisonneuve, MD^25*, Emmanuel Bachy^26,27*, Guillaume Cartron, MD, PhD^28*, Arnaud Jaccard, MD, PhD^29*, Olivier Tournilhac^30*, Cedric Rossi, MD^31*, Aurore Perrot^32*, Jean-Alain Martignoles^33*, Herve Tilly, MD, PhD³⁴ and Gandhi Damaj, MD, PhD³⁵

¹CHU, Caen, France
²APHM, Bobigny, France
³Hematologie, Centre Hospitalier Universitaire, Université de Lille 2, Lille, France
⁴Service d’Hématologie et Thérapie Cellulaire, UMR CNRS 7292, CHU de Tours, Tours, France
⁵Hematology, CHU, Angers, France
⁶CHU Curie, paris, France
⁷APHP Necker, Paris, France
⁸APHP Necker, PARIS CEDEX 15, France
⁹Institut Paoli Calmettes, Marseille, France
¹⁰Hematology, Hopital Avicenne, Bobigny, France
¹¹CHU, Strasbourg, France
¹²Hospital, Saint Quentin, France
¹³CHU, Valenciennes, France
¹⁴Stanford University, Stanford, CA
¹⁵Hematology Department, Centre hospitalier Sud Francilien, Corbeil, France
¹⁶Hospital, Meaux, France
¹⁷Hôpital de Boulogne-sur-Mer, Boulogne-sur-Mer, France
¹⁸Haematology Department, Caen University Hospital, Caen, France
¹⁹CHU, CAEN CEDEX 5, France
²⁰CHU DE CAEN, Caen, France
²¹CHU, CAEN, France
²²Department of Hematology, Hospices Civils de Lyon, Pierre-Benite, France
²³Hematology, Centre Hospitalier Universitaire, Amiens, France
²⁴Chu Amiens, Salouel, France
²⁵Oncology and Hematology Department, CH, La Roche-sur-Yon, France
²⁶Hospital, Lyon, TX, France
²⁷Hospital, Lyon, France
²⁸Centre Hospitalier Regional Et Universitaire De Tours, Montpellier, France
²⁹Department of Hematology, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts, CHU Limoges, Limoges, France
³⁰CHU Clermont Ferrand, Clermont Ferrand Cedex 1, France
³¹CHU, Dijon, France
³²CHU, Vandoeuvre Les Nancy, France
³³Saint-Etienne University Hospital, Saint-Etienne, France
³⁴Service d’Hématologie Clinique, Centre Henri Becquerel, Rouen Cedex, France
³⁵Hematology Department, CHU Caen, Caen, France

Katharina Lisenko, MD^1*, Fabienne McClanahan, MD, PhD^2*, Tilman Schöning, MD^3*, Mark-Alexander Schwarzbich, MD^4*, Martin Cremer, MD^5*, Tobias Dittrich, MD^6*, Anthony D. Ho, MD⁷ and Mathias Witzens-Harig, MD^8*

¹Department of Hematology, University Hospital, Heidelberg, Germany
²Centre for Haemato-Oncology, Queen Mary University of London, London, United Kingdom
³University Pharmacy, University Hospital Heidelberg, Heidelberg, Germany
⁴Department of Hematology, University of Heidelberg, Heidelberg, Germany
⁵Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany
⁶Amyloidosis Center, University Hospital Heidelberg, Heidelberg, Germany
⁷Dept. Med. V, University Hospital Heidelberg, Heidelberg, Germany
⁸Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany

Yuko Mishima, MD, PhD^1*, Masahiro Yokoyama, MD^1*, Noriko Nishimura, MD, PhD^1*, Kyoko Ueda, MD^1*, Tadahiro Gunji, MD^1*, Hideaki Nitta, MD, PhD¹, Yoshiharu Kusano, MD^1*, Norihito Inoue, MD^1*, Anna Takahashi, MD^1*, Naoko Tsuyama, MD^2*, Kengo Takeuchi, MD, PhD^2*, Yasuhito Terui, MD, PhD¹ and Kiyohiko Hatake, MD, PhD¹

¹Department of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
²Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Emilia Pardal, MD, PhD^1*, Eva Diez-Baeza, PhD^2*, Eva González-Barca, MD, PhD^3*, Tomas Garcia-Cerecedo, MD, PhD^4*, Encarna Monzo, MD, PhD^5*, Juan-Manuel Sancho^6*, Jose Maria Moraleda, MD, PhD^7*, Raul Cordoba, MD, PhD^8*, Fatima De la Cruz, MD, PhD^9*, JA Queizan, MD, PhD^10*, Maria Rodriguez-Salazar, MD, PhD^11*, JA Hernández-Rivas, MD, PhD^12*, Belen Navarro, MD, PhD^13*, Rosana Diez-Angulo, MD, Phd^14*, Maria Cruz Viguria, MD, PhD^15*, Maria Vahi, MD, PhD^16*, Maria Jesús Peñarrubia, MD, PhD^17*, Monica Sanchez, PhD^18*, Miguel Canales, MD, PhD¹⁹, Tomas Gonzalez, MD^20*, Sara Alonso, MD^21*, Maria Dolores Caballero, MD, PhD^22* and Alejandro Martin, MD, PhD^23*

¹Virgen del Puerto University, Plasencia, Spain
²University Hospital of Salamanca, Salamanca, Spain
³Department of Hematology / Institut Català d‘Oncologia, Hospital Duran i Reynals, Barcelona, Spain
⁴Arnau de Vilanova Hospital, Lleida, Spain
⁵Arnau de Vilanova Hospital, Valencia, Spain
⁶ICO-Germans Trias i Pujol Hospital., Badalona, Spain
⁷Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
⁸Fundación Jiménez-Díaz Hospital, Madrid, Spain
⁹Hematology and Hemotherapy Unit, Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Rocío, Seville, Spain
¹⁰Segovia General Hospital, Segovia, Spain
¹¹Canary Islands Universitiy Hospital, Santa Cruz de Tenerife, Spain
¹²Infanta Leonor Hospital, Madrid, Spain
¹³Puerta de Hierro Hospital, MADRID, Spain
¹⁴Txagorritxu Hospital, Vitoria, Spain
¹⁵Complejo Universitario Navarra, Pamplona, Spain
¹⁶Sevilla, Nuestra Señora de Valme Hospital, Sevilla, Spain
¹⁷Clinical Hospital of Valladolid, Valladolid, Spain
¹⁸GELTAMO, Madrid, Spain
¹⁹Hospital Universitario La Paz, Madrid, Spain
²⁰Compleo Hospitalario de Burgos, Burgos, Spain
²¹Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
²²Universitiy Hospital of Salamanca, Universitiy Hospital of Salamanca, Salamanca, Spain
²³Universitiy Hospital of Salamanca, Salamanca, Spain

Karin Hohloch, PD Dr.^1*, Bettina Altmann^2*, Michael Pfreundschuh, MD³, Markus Loeffler, Prof.^2*, Norbert Schmitz, MD⁴, Marita Ziepert, PhD^2* and Lorenz H. Truemper, MD, PhD⁵

¹Hematology and Oncology, Department of Hematology and Medical Oncology, University of Goettingen, Germany, Goettingen, Germany
²Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Germany, Leipzig, Germany
³Department of Hematology and Oncology, University Clinic of Saarland, Homburg, Germany, Homburg/Saar, Germany
⁴Abt. Hämatologie und Stammzelltransplantation, ASKLEPIOS Klinik St. Georg, Hamburg, Germany
⁵Hematology and Oncology, University Medicine Goettingen, Goettingen, Germany

Marc Sorigue, MD^1*, Juan-Manuel Sancho^2*, Santiago Mercadal, MD^3*, Ruben Fernández-Álvarez, MD^4*, Helena Pomares, MD^5*, Olga Garcia^6*, Eva González-Barca, MD, PhD^7*, Esther González-García, MD^8*, Miriam Moreno, MD^9*, Cristina Motlló, MD^10*, Montserrat GarcÃa, MD^1*, Jose-Tomas Navarro, MD, PhD^11*, Eva domingo-Domenech, MD^12*, Evarist Feliu, MD, PhD^13*, Anna Sureda, MD, PhD^14* and Josep-Maria Ribera, MD, PhD¹⁵

¹Servicio de Hematología Clínica, Institut Català d’Oncologia, Institut de Recerca contra la Leucemia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, badalona, Spain
²ICO-Germans Trias i Pujol Hospital., Badalona, Spain
³ICO-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain
⁴Servicio de Hematología, Hospital de Cabueñes,, Gijon, Spain
⁵Servicio de Hematología Clínica, Institut Català d’Oncologia, Hospital Duran i Reynals, L’Hospitalet de Llobregat, Spain
⁶Servicio de Hematologia, Hospital Germans Trias i Pujol, Badalona, Spain
⁷Department of Hematology / Institut Català d‘Oncologia, Hospital Duran i Reynals, Barcelona, Spain
⁸Servicio de Hematología, Hospital de Cabueñes, Gijón, Spain
⁹Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰Servicio de Hematología Clínica, Institut Català d’Oncologia, Institut de Recerca contra la Leucemia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona,, badalona, Spain
¹¹Department of Hematology, ICO-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
¹²2Servicio de Hematología Clínica, Institut Català d’Oncologia, Hospital Duran i Reynals, L’Hospitalet de Llobregat, Spain
¹³Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
¹⁴Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
¹⁵Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain

Zeinab A Abou Yehia, MD^1*, George Mikhaeel, MD^2*, Grace Smith, MD^1*, Chelsea C Pinnix, MD PhD^3*, Sarah A Milgrom, MD^3*, Michelle A. Fanale, MD⁴, Jay Reddy, MD^5*, Eleanor Osborne, MD^3*, Mani Akhtari, MD^6*, Jillian Gunther, MD^3*, Pamela Allen, PHD^3* and Bouthaina S. Dabaja, MD³

¹Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
²Medical Oncology, Guy's and St Thomas' NHS Trust, London, United Kingdom
³Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Radiation Oncology, The Univeristy of Texas MD Anderson Cancer Center, Houston, TX
⁶Radiation Oncology, University of Texas Medical Branch at Galveston, Galveston, TX

Naoto Tomita¹, Taisei Suzuki^2*, Kazuho Miyashita^3*, Wataru Yamamoto^4*, Kenji Motohashi^5*, Takayoshi Tachibana^6*, Hirotaka Takasaki^7*, Rika Kawasaki^3*, Maki Hagihara^5*, Chizuko Hashimoto^8*, Sachiya Takemura^9*, Hideyuki Koharazawa^10*, Etsuko Yamazaki, MD¹, Jun Taguchi^10*, Katsumichi Fujimaki^3*, Hiroyuki Fujita¹¹, Rika Sakai⁴, Shin Fujisawa^5*, Shigeki Motomura^4*, Keisuke Kawamoto^12*, Hirohito Sone^12* and Jun Takizawa^12*

¹Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
²Hematology, Yokosuka City Hospital, Yokouka, Japan
³Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan
⁴Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
⁵Hematology, Yokohama City University Medical Center, Yokohama, Japan
⁶Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
⁷Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
⁸Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan
⁹Internal Medicine, Yokohama Ekisaikai Hospital, Yokohama, Japan
¹⁰Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan
¹¹Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan
¹²Hematology, Endocrinology, and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan

Yuankai Shi, MD, PhD^1*, Mei Dong, MD^2*, Jun Zhu, MD³, Daobin Zhou, MD^4*, Huiqiang Huang, MD⁵, Ping Tu, MD^6*, Weijing Zhang, MD^7*, Xiaonan Hong, MD^8*, Xielan Zhao, MD^9*, Jianfang Sun, MD^10*, Yuehua Liu, MD^11*, Lugui Qiu, MD, PhD¹², ZhiXiang Shen, MD^13*, Jifeng Feng, MD^14* and Xiaoyan Ke, MD, PhD^15*

¹Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
²Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
³Department of Lymphatic Oncology, Beijing Cancer Hospital, Beijing, China
⁴Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁵Department of Medical Oncology, Cancer Center of Sun Yat-sen University,State Key Laboratory of Oncology in Southern China, Guangzhou, China
⁶Department of Dermotology, Peking University First Hospital, Beijing, China
⁷Department of Lymphoma, 307 Hospital of PLA, Beijing, China
⁸Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
⁹Department of Hematology, The Xiangya Hospital of Central-South University, Changsha, China
¹⁰Department of Pathology, Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, China
¹¹Department of Dermotology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
¹²State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Tianjin, China
¹³Department of hematology, the Ruijin Hospital of Shanghai Jiaotong University, Shanghai, China
¹⁴Department of Hematology and Oncology, Jiangsu Cancer Hospital, Nanjing, China
¹⁵Department of Hematology, Third Affiliated Hospital of Peking University, Beijing, China

Eva González-Barca, MD, PhD^1*, Estrella Carrillo^2*, Carlos Grande, MD^3*, Alejandro Martín^4*, Mónica Coronado^5*, Santiago Montes-Moreno^6*, Jaime Perez de Oteyza^7*, Concepción Nicolas^8*, Juan-Manuel Sancho^9*, Luis Palomera, MD PhD^10*, Javier Lopez Sr., MD, PhD^11*, Armando Lopez-Guillermo¹², Francisco Javier Peñalver^13*, José Ángel Hernández, MD^14*, Maria Jose Ramirez^15*, Isidro Jarque^16*, Joan Bargay, MD^17*, Mª José Rodríguez^18*, Miguel Canales¹⁹, Carmen Albo^20*, Maite Encuentra^21* and Dolores Caballero^4*

¹Department of Hematology / Institut Català d‘Oncologia, Hospital Duran i Reynals, Barcelona, Spain
²Department of Hematology / Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Sevilla, Spain
³Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
⁴Department of Hematology / IBSAL, Hospital Universitario de Salamanca, Salamanca, Spain
⁵Department of Nuclear Medicine, Hospital Universitario La Paz, Madrid, Spain
⁶Department of Pathology / IFIMAV, Hospital Universitario Marqués de Valdecilla, Santander, Spain
⁷Department of Hematology, Hospital Universitario Sanchinarro, Madrid, Spain
⁸Department of Hematology, Hospital Central de Asturias, Asturias, Spain
⁹Servicio de Hematologia, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰Department of Hematology, Hospital Universitario Lozano Blesa, Zaragoza, Spain
¹¹Department of Hematology, Hospital Ramon y Cajal, Madrid, Spain
¹²Hematology, Hospital Clinic, Barcelona, Spain
¹³Department of Hematology, Hospital Universitario Fundación Alcorcon, Madrid, Spain
¹⁴Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain
¹⁵Department of Hematology, Hospital de Jerez de la Frontera, Jerez de la Frontera. Cádiz, Spain
¹⁶Department of Hematology, Hospital Universitario La Fe, Valencia, Spain
¹⁷Department of Hematology. Hospital Son Llatzer, Palma de Mallorca, Spain
¹⁸Department of Hematology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
¹⁹Department of Hematology, Hospital Universitario La Paz, Madrid, Spain
²⁰Department of Hematology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
²¹Department of Hematology / Institut Catalá d‘Oncologia, Hospital Duran i Reynals, L'Hospitalet de LLobregat, Spain

Takuro Matsumoto, MD^*, Yuhei Shibata, MD^*, Nobuhiko Nakamura, MD, PhD^*, Hiroshi Nakamura, MD^*, Soranobu Ninomiya, MD, PhD, Junichi Kitagawa, MD, PhD^*, Yasuhito Nannya, MD, PhD^*, Masahito Shimizu, MD, PhD^*, Takeshi Hara, MD, PhD and Hisashi Tsurumi, MD, PhD

First Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

Andrea Kühnl, MD^1*, David Cunningham^1*, Nicholas Counsell^2*, Eliza A Hawkes^3*, Wendi Qian, PhD^4*, Paul Smith^2*, Nick Chadwick^2*, Anthony Lawrie^5*, Paul Mouncey^2*, Andrew S Jack⁶, Christopher Pocock⁷, Kirit Ardeshna, MD^8*, John Radford^9*, Andrew McMillan, PhD¹⁰, John Davies^11*, Deborah Turner^12*, Anton Kruger^13*, Peter W Johnson, MD¹⁴, Joanna Gambell^2* and David C Linch, FMedSci⁸

¹The Royal Marsden Hospital, London and Surrey, United Kingdom
²Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom
³Austin Hospital, Heidelberg, Australia
⁴Cancer Theme and Medical Research Council Biostatistics, Cambridge Cancer Trials Centre, Cambridge, United Kingdom
⁵UCL Cancer Institute, Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom
⁶HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁷East Kent Hospitals, Canterbury, United Kingdom
⁸University College London, London, United Kingdom
⁹The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
¹⁰Centre for Clinical Haematology, Nottingham City Hospitals NHS Trust, Nottingham, United Kingdom
¹¹Western General Hospital, Edinburgh, United Kingdom
¹²Torbay Hospital, Torquay, United Kingdom
¹³Royal Cornwall Hospital, Truro, United Kingdom
¹⁴Cancer Research UK Clinical Centre, University of Southampton, Southampton, United Kingdom

Evren Ozdemir, MD^*, Alma Aslan, MD^*, Alev Turker, MD^*, Ibrahim Barista, MD^* and Ayse Kars, MD^*

Institute of Cancer, Department of Medical Oncology, Hacettepe University, Ankara, Turkey

Jackie Vandermeer, BS^1,2*, Allison M Winter, MD^3*, Ajay K. Gopal, MD^1,2, Ryan D. Cassaday, MD^1,2, Brian T. Hill, MD, PhD⁴, Andrei R. Shustov, MD^5,6, Andrew J. Cowan, MD^1,2, David G. Maloney, MD, PhD^1,2, Mazyar Shadman, MD, MPH^1,2*, Brian G. Till, MD^1,2, Lorinda Soma, MD^7*, Oliver W. Press, MD, PhD^1,2 and Stephen D. Smith, MD^1,2

¹Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH
⁴Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle
⁶Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
⁷Department of Laboratory Medicine, University of Washington, Seattle, WA

Ehsan Malek, MD¹, Arun Sendilnatha, MD^2*, Mahender Yellu, MD, MBBS², Andrew Petersen, MD^3*, Mariano Fernandez-ulloa, MD^4*, Marcos de Lima, MD^1* and James J. Driscoll, MD, PhD^5,6*

¹Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH
²Hematology Oncology Division, University of Cincinnati, Cincinnati, OH
³Internal Medicine Department, University of Cincinnati, Cincinnati, OH
⁴Nuclear Medicine Department, University of Cincinnati, Cincinnati, OH
⁵The Vontz Center for Molecular Studies, University of Cincinnati, Cincinnati, OH
⁶Division of Hematology and Oncology, University of Cincinnati, Cincinnati, OH

Moaath Mustafa Ali, MD^1*, Basel Rouphail, MD, MBA^2*, Robert M. Dean, MD², Brian T. Hill, MD, PhD², Deepa Jagadeesh, MD, MPH², Brad Pohlman, MD² and Mitchell R. Smith, MD, PhD²

¹Internal Medicine, Cleveland Clinic, Cleveland, OH
²Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Huiqiang Huang, MD^1,2, Yan Gao^3*, XiaoXiao Wang^3*, Qingqing Cai, MD^1*, QiChun Cai^4*, Bing Bai^5*, Wei Zhao^5*, Zheng Yan^5*, Wenqi Jiang, MD, PhD^1*, Zhongjun Xia, MD⁶ and ZhiMing Li^3*

¹Department of Medical Oncology, Cancer Center of Sun Yat-sen University,State Key Laboratory of Oncology in Southern China, Guangzhou, China
²State Key Laboratory of Oncology in South China, Guangzhou, China
³Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⁴Department of Medical Oncology, Guangdong General Hospital,Guangdong Academy of Medical Sciences, Guangzhou, China
⁵Sun Yat-Sen University Cancer Center, Guangzhou, China
⁶Dept. of Medical Oncology, Cancer Center of SUMS, Guangzhou, China

Young-Woo Jeon^1*, Jae-Ho Yoon, M.D.^1*, Sung-Eun Lee, M.D.^1*, Ki-Seong Eom^1*, Yoo-Jin Kim², Hee-Je Kim, M.D.¹, Seok Lee², Chang-Ki Min, M.D.^1*, Jong Wook Lee³, Woo-Sung Min, M.D.^1* and Seok-Goo Cho, M.D.¹

¹Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, Seoul St. Mary’s hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
²Hematology, Internal Medicine, Catholic BMT Center, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea
³Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Daniela Cárdenas-Araujo, MD^1*, Xitlaly Judith Gonzalez-Leal, MD² and David Gomez-Almaguer, MD³

¹Servicio de Hematología, Hospital Universitario Dr. Eleuterio González, Monterrey, Mexico
²Servicio de Hematologia, Hospital Universitario Dr. Jose Eleuterio Gonzalez Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
³Hematology, Hospital Universitario, Monterrey, Mexico

Sylvain Choquet, MD^1*, Adrien Grenier, MD^2*, Caroline Houillier, MD^3*, Carole Soussain, MD, PhD⁴, Marie Pierre Moles, MD^5*, Thomas Gastinne, MD^6*, Nathalie Cassoux, MD^7*, Helene merle Beral, MD^8*, Damien roos Weil, MD^2*, Veronique Leblond, MD¹ and Khe hoang Xuan, MD, PHD^3*

¹Department of Clinical Hematology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France
²Department of clinical haematology, Pitie-Salpetriere hospital, APHP, Paris, France
³Department of neuro-oncology, Pitie-Salpetriere hospital, APHP, Paris, France
⁴Dept. of hematology, Hôpital René Huguenin - Institut Curie, Saint-Cloud, France
⁵Hematology Department, CHU, Angers, France
⁶Hematology Department, CHU Nantes, Nantes, France
⁷ophtalmology, centre Rene Huguenin, Paris, France
⁸Department of biological haematology, Pitie-Salpetriere hospital, APHP, Paris, France